In its upcoming report, Collegium Pharmaceutical (COLL) is predicted by Wall Street analysts to post quarterly earnings of $1.56 per share, reflecting an increase of 23.8% compared to the same period last year. Revenues are forecasted to be $143.73 million, representing a year-over-year increase of 6%. The consensus EPS estimate for the quarter has been revised 0.2% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initia ...